Prana Biotechnology Limited (PRAN) Stock Rating Upgraded by Zacks Investment Research

Prana Biotechnology Limited (PRAN) Stock Rating Upgraded by Zacks Investment Research


According to Zacks, "Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses.



from Biotech News